Literature DB >> 22736157

[Study of Health in Pomerania (SHIP). Concept, design and selected results].

H Völzke1.   

Abstract

The Study of Health in Pomerania (SHIP) is a population-based project conducted in Northeast Germany. The main purpose is to assess prevalence and incidence of common risk factors, subclinical disorders and clinical diseases, and to investigate associations and interactions among them. The first SHIP cohort included 4,308 individuals at baseline (SHIP-0, response 68.8%) and 3,300 after 5 years (SHIP-1, response 83.6%). Currently, data are being collected for the 11-year follow-up (SHIP-2). In parallel, baseline examinations of a second, independent cohort (SHIP-TREND) are being conducted. The assessments range from interviews to laboratory analyses; somatometric and blood pressure measurements; dental, dermatological, cardio-metabolic and various ultrasound examinations; to more demanding methods such as cardiopulmonary exercise tests, sleep monitoring and whole-body magnetic resonance imaging. Analyses of baseline SHIP-0 data revealed valuable information on the health status of the West Pomeranian population, and generally confirmed the hypothesis of an accumulation of common risk factors and diseases in this region. The population-based character of the study and the profound information on potential exclusion criteria allow for analyses of population-representative reference values. The comprehensive data set offers various opportunities for association studies to gain new insight into the complex relations among risk factors, subclinical and clinical disease parameters. SHIP is an established population-based project conducted in Northeast Germany with a very comprehensive characterization of study subjects. After the data collection for SHIP-2 and SHIP-TREND is finished, a comprehensive data set will be available that describes complex interactions of health determinants.

Entities:  

Mesh:

Year:  2012        PMID: 22736157     DOI: 10.1007/s00103-012-1483-6

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  19 in total

Review 1.  [Pain registries and similar data collections : A systematic review].

Authors:  A Freytag; B Scriba; U Kaiser; W Meißner
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

2.  Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome.

Authors:  Malte Christoph Rühlemann; Britt Marie Hermes; Corinna Bang; Shauni Doms; Lucas Moitinho-Silva; Louise Bruun Thingholm; Fabian Frost; Frauke Degenhardt; Michael Wittig; Jan Kässens; Frank Ulrich Weiss; Annette Peters; Klaus Neuhaus; Uwe Völker; Henry Völzke; Georg Homuth; Stefan Weiss; Harald Grallert; Matthias Laudes; Wolfgang Lieb; Dirk Haller; Markus M Lerch; John F Baines; Andre Franke
Journal:  Nat Genet       Date:  2021-01-18       Impact factor: 38.330

3.  [Prevalence of arterial hypertension in the population of Western Germany: Heinz Nixdorf Recall Study].

Authors:  M Horacek; S Möhlenkamp; A A Mahabadi; S Churzidse; S Moebus; K-H Jöckel; R Erbel
Journal:  Herz       Date:  2012-11       Impact factor: 1.443

Review 4.  [Incidental radiological findings].

Authors:  S Weckbach; C L Schlett; R C Bertheau; H-U Kauczor
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

5.  Socioeconomic factors do not predict sleep apnea in a population sample from Mecklenburg-Western Pomerania, Germany.

Authors:  Markus Krüger; Anne Obst; Olaf Bernhardt; Ralf Ewert; Thomas Penzel; Beate Stubbe; Ingo Fietze; Tatyana Ivanovska; Reiner Biffar; Amro Daboul
Journal:  Sleep Breath       Date:  2022-04-29       Impact factor: 2.816

6.  Changes in body weight and obesity status in German adults: results of seven population-based prospective studies.

Authors:  M Haftenberger; G B M Mensink; B Herzog; A Kluttig; K H Greiser; B Merz; U Nöthlings; S Schlesinger; S Vogt; B Thorand; A Peters; T Ittermann; H Völzke; S Schipf; J Neamat-Allah; T Kühn; R Kaaks; H Boeing; U Bachlechner; C Scheidt-Nave; A Schienkiewitz
Journal:  Eur J Clin Nutr       Date:  2015-10-28       Impact factor: 4.016

7.  Genetic Variants Associated with Circulating Parathyroid Hormone.

Authors:  Cassianne Robinson-Cohen; Pamela L Lutsey; Marcus E Kleber; Carrie M Nielson; Braxton D Mitchell; Joshua C Bis; Karen M Eny; Laura Portas; Joel Eriksson; Mattias Lorentzon; Daniel L Koller; Yuri Milaneschi; Alexander Teumer; Stefan Pilz; Maria Nethander; Elizabeth Selvin; Weihong Tang; Lu-Chen Weng; Hoi Suen Wong; Dongbing Lai; Munro Peacock; Anke Hannemann; Uwe Völker; Georg Homuth; Matthias Nauk; Federico Murgia; Jack W Pattee; Eric Orwoll; Joseph M Zmuda; Jose Antonio Riancho; Myles Wolf; Frances Williams; Brenda Penninx; Michael J Econs; Kathleen A Ryan; Claes Ohlsson; Andrew D Paterson; Bruce M Psaty; David S Siscovick; Jerome I Rotter; Mario Pirastu; Elizabeth Streeten; Winfried März; Caroline Fox; Josef Coresh; Henri Wallaschofski; James S Pankow; Ian H de Boer; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 14.978

8.  The ophthalmic branch of the Gutenberg Health Study: study design, cohort profile and self-reported diseases.

Authors:  René Höhn; Ulrike Kottler; Tunde Peto; Maria Blettner; Thomas Münzel; Stefan Blankenberg; Karl J Lackner; Manfred Beutel; Philipp S Wild; Norbert Pfeiffer
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  Sex hormones and quantitative ultrasound parameters at the heel in men and women from the general population.

Authors:  Konrad Pätzug; Nele Friedrich; Hanna Kische; Anke Hannemann; Henry Völzke; Matthias Nauck; Brian G Keevil; Robin Haring
Journal:  Bone Rep       Date:  2017-08-18

10.  Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study.

Authors:  Velibor Čabarkapa; Branislava Ilinčić; Mirjana Đerić; Isidora Radosavkić; Mirko Šipovac; Jan Sudji; Veljko Petrović
Journal:  J Med Biochem       Date:  2017-04-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.